Amgen Inc (NASDAQ: AMGN)
DRUGS - BiotechnologySector: Health Care
Stock price data as of 03/15/2024
Closing price: 268.87
Support price level: | N/A |
Resistance price level: | $275.01 |
Relative strength index (14-day RSI) | 26.9 |
Beta | 0.46 |
- AMGN is one of this month's worst performers with a return of -7.0%, underperforming 90 percent of stocks in the S&P-100.
- Volatility is forecast to fall over the next month.
- With RSI < 30, AMGN is oversold. Odds slightly favor a short-term price reversal.
- Price broke below prior support level - a short-term bearish signal.
Low | High | Price as % of Range |
$214.27 | $324.56 | 54.7% |
200 day | 50 day | 20 day | 10 day |
$265.68 | $294.98 | $278.45 | $274.75 |
Historical (5 year) |
Last month | Current estimate | Next month forecast |
25.3% | 29.7% | 22.4% | 24.0% |
- 6.1% in the next week.
- 13.6% in the next month.
- 42.2% in the next year.